---
$id: https://graph.org.ai/products/commodity/51281912
$type: Product
source: UNSPSC
code: "51281912"
title: "Puromycin aminonucleoside"
class: "51281900"
classTitle: "Antineoplastics"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Puromycin aminonucleoside

**UNSPSC Code**: 51281912
**Class**: [Antineoplastics](Antineoplastics.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a protein synthesis inhibitor and miscellaneous antineoplastic antibiotic with the molecular formula C12H18N6O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0Q580U88V8, chemically known as 6-(dimethylamino)-9-(3-amino-3-deoxy-.beta.-d-ribofuranosyl)purine, but more generally known as puromycin aminonucleoside, which bears US NIH Compound Identifier 1599. European Medicines Agency schedules puromycin aminonucleoside or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10161MIG. Most nations, for tariff purposes, schedule puromycin aminonucleoside under HS 29419000. SMILES: CN(C)C1C2C(NCN1)N(CN2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)N)O.

